Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mediphage Bioceuticals

Mediphage Bioceuticals
2015 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
2 INVESTORS
Description

Developer of gene therapy platforms designed to exploit safe and effective bacteriophage-based therapeutics for gene delivery. The company's platform develops safe bacteriophage-based therapeutics such as DNA ministrings for cost-effective and personalized management of cancer and other chronic diseases and for therapeutic DNA delivery and genetic manipulation, enabling patients to receive safe, effective and efficiently produced gene therapeutic systems.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Biotechnology
Primary Office
  • 661 University Avenue, Suite 1300
  • MaRS Center, West Tower
  • Toronto, Ontario M5G 0B3
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mediphage Bioceuticals’s full profile, request a free trial.

Mediphage Bioceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 26-Apr-2018 00000 Completed Startup
2. Accelerator/Incubator 24-Feb-2017 00000 Completed Startup
1. Seed Round 01-Mar-2016 $370K $370K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Mediphage Bioceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Illumina PE-Backed Company Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0

Mediphage Bioceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Roderick Slavcev Ph.D Founder & Chief Executive Officer
Vanessa Ferlaino Chief Operating Officer
Jonathan Blay Ph.D CSO